| ²é¿´: 1389 | »Ø¸´: 0 | |||
TAINSTÌú³æ (ÕýʽдÊÖ)
|
[½»Á÷]
¼Ù¶à¾§ÐÍÒ©ÎïµÄ±íÕ÷
|
| A large percentage of pharmaceutical products are formulated as solids due to their ease of manufacture and packaging, and for the convenience of the patient. However, pharmaceutical compounds can often exist in more than one solid state form, including polymorphs and hydrates (pseudo-polymorphs). Since the solid state structure has potentially significant impact on the stability and bioavailability of the final product, it is essential that the solid state energetics of the compound be characterized and understood. |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : ¼Ù¶à¾§ÐÍÒ©ÎïµÄ±íÕ÷.pdf
2016-07-05 09:21:52, 338.83 K
» ²ÂÄãϲ»¶
ÊÛSCIÎÄÕ£¬ÎÒ:8O.5.5.1O.54,¿ÆÄ¿È«,¿ÉÊ®¼±
ÒѾÓÐ3È˻ظ´
ÊÛSCIÒ»ÇøÎÄÕ£¬ÎÒ:8.O.55.1.O.54,¿ÆÄ¿ÆëÈ«,¿ÉÙ¤¼±
ÒѾÓÐ3È˻ظ´
ÎÒ¾ÍÊÇÉêÇëÒ»¸öÃæÉÏÏîÄ¿¶øÒÑ£¬ÕâÆÀÉóÒâ¼ûÊǰ´ÕÕ½ÜÇàµÄÌõ¼þÆÀµÄ°É£¿
ÒѾÓÐ3È˻ظ´
ÓжàÉÙÈËÊǽñÌì²éϵͳ֪µÀ½á¹ûµÄ£¿
ÒѾÓÐ18È˻ظ´
¹ú×ÔÈ»ÆÀÉóÒâ¼û
ÒѾÓÐ15È˻ظ´
Ϊʲô×ÊÖúÊý¸÷´ó¸ßУ¶¼´´Ð¸ߣ¬×Ô¼ºÉêÇëÔõô¾ÍÕâôÄÑ
ÒѾÓÐ13È˻ظ´
¹ú×ÔÈ»ÃæÉϸ´ÅÌ~»¶ÓÌÖÂÛ
ÒѾÓÐ14È˻ظ´
ϵͳ²é²»µ½
ÒѾÓÐ11È˻ظ´
ÓÐûÓÐÈÔûÊÕµ½ÐÅÏ¢µÄ
ÒѾÓÐ3È˻ظ´
µ¼Ê¦Í²ۣºÎÒÔõô̯ÉÏÁËÕâô¸ö¼«Æ·Ñо¿Éú£¡
ÒѾÓÐ8È˻ظ´









»Ø¸´´ËÂ¥